drugset / Trial / NCT02155829

Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD)

NCT02155829

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Riluzole is effective in the augmentation treatment of post-traumatic stress disorder (PTSD) that is experienced by Active Duty military service members and Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) veterans who have not had symptom reduction after one or more kinds of medications or therapies.

Timeline

Start
2013-07
Primary completion
2017-10-30
Completion
2017-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Riluzole Small molecule 200 mg Oral